MTAP and congenital T-cell immunodeficiency: Despite the survival advantage that MTAP deletion confers to the OS TME through T cell deficiency, we identified a related metabolic vulnerability in DuNN shMtap tissues—activation of methionine metabolism (Figure S10H), a pathway previously reported to be synthetically lethal with MTAP deletion.14